ARCHIVES

ODAC Reviews Post-Marketing Studies for Eight Indications

This article is from The Cancer Letter archive.

Vol. 29 No. 08 | February 21, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994

DCE Reorganization Planned To Stem Departures, Stabilize

March 24, 1995

5-FU/Levamisole A community Success Story; Trials With Untreated Control Revised Or Dropped

October 13, 1989

Also in this 8-page issue: Rep. James Greenwood to become president of Biotechnology Industry Association.

July 30, 2004

Treatment research Reports Summarized; New MTX Rescues

May 6, 1977

NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”

May 7, 1993